Generali's Natixis Deal Remains Key as Balancing Act Plays out -- Market Talk

Dow Jones
2025/06/09

0926 GMT - The most critical question for Generali's shareholders is whether the asset-management joint venture with Groupe BPCE's Natixis will be approved, AlphaValue says in a research note. The battle for influence at the Italian insurer is heating up as its main shareholder, Mediobanca, seeks approval to buy Banca Generali with the stake it owns in the bank's parent. The potential for economies of scale from the Natixis deal more than offset the risks but meaningful obstacles remain, analyst Antoine Bouchetoux writes. These include opposition from Roman tycoon Caltagirone, a top shareholder, and political concerns around the insurer's holding of Italian government bonds. The transaction is being reviewed by the state and is unlikely to go ahead if authorities formally oppose it, he notes. (elena.vardon@wsj.com)

 

(END) Dow Jones Newswires

June 09, 2025 05:26 ET (09:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10